Literature DB >> 2764602

Thrombotic obstruction of disc valves: clinical recognition and surgical management.

G J Kontos1, H V Schaff, T A Orszulak, F J Puga, J R Pluth, G K Danielson.   

Abstract

Twenty-seven patients underwent reoperation because of thrombotic obstruction of a disc-type cardiac valve prosthesis. Preoperative clinical features included effort dyspnea in 81%, new-onset angina in 44%, a new murmur in 89%, and an abnormal opening or closing sound associated with the prosthetic valve in 56%. Symptoms were present for 1 week or more before reoperation in 86%, although many patients were referred only after acute exacerbation of heart failure and development of pulmonary edema. Noninvasive studies confirmed prosthetic valve malfunction in only 33%, but cardiac catheterization documented thrombotic obstruction in all 15 patients in whom it was performed. In 14 of the 27 patients, prothrombin time was in the therapeutic range at the time of admission. Prompt reoperation for valve replacement or thrombectomy was performed with an operative mortality of 11%, and long-term outcome was satisfactory in all but 1 hospital survivor. These findings emphasize the importance of considering the diagnosis of thrombosed heart valves in patients with mechanical heart valves who are seen with nonspecific symptoms.

Entities:  

Mesh:

Year:  1989        PMID: 2764602     DOI: 10.1016/0003-4975(89)90177-x

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  17 in total

1.  Dysfunction of mechanical heart valve prosthesis: experience with surgical management in 48 patients.

Authors:  Wei-Guo Ma; Bin Hou; Adiljan Abdurusul; Ding-Xu Gong; Yue Tang; Qian Chang; Jian-Ping Xu; Han-Song Sun
Journal:  J Thorac Dis       Date:  2015-12       Impact factor: 2.895

2.  Acute thrombotic occlusion of a prosthetic valve--treatment with tissue plasminogen activator.

Authors:  J C Roxburgh; P J Keeling; G E Venn
Journal:  J R Soc Med       Date:  1992-03       Impact factor: 5.344

Review 3.  Thrombolysis as first choice therapy in prosthetic heart valve thrombosis. A study of 68 patients.

Authors:  Fidel Manuel Cáceres-Lóriga; Horacio Pérez-López; Karel Morlans-Hernández; Humberto Facundo-Sánchez; José Santos-Gracia; Juan Valiente-Mustelier; Felipe Rodiles-Aldana; Maria Acelia Marrero-Mirayaga; Blas Y Betancourt; Pedro López-Saura
Journal:  J Thromb Thrombolysis       Date:  2006-04       Impact factor: 2.300

4.  Listen to your heart.

Authors:  Iacopo Bertolozzi; Angelo Pucci; Pietro Amedeo Modesti
Journal:  Intern Emerg Med       Date:  2009-02-19       Impact factor: 3.397

5.  Fibrinolytic therapy for mechanical pulmonary valve thrombosis.

Authors:  Zahra Khajali; Shabnam Mohammadzadeh; Majid Maleki; Mohammad Mehdi Peighambari; Anita Sadeghpoor; Alireza Ghavidel; Behrad Elahi; Mohammadreza Mirzaaghayan
Journal:  Pediatr Cardiol       Date:  2014-08-22       Impact factor: 1.655

6.  Detection of acute thrombosis of mitral tilting disk prosthesis by transesophageal echocardiography.

Authors:  P Ius; A Giacomin; A Cavarzerani; C Valfré
Journal:  Int J Card Imaging       Date:  1994-12

7.  Prevalence of pannus formation after aortic valve replacement: clinical aspects and surgical management.

Authors:  Yoshimasa Sakamoto; Kazuhiro Hashimoto; Hiroshi Okuyama; Shinichi Ishii; Taguchi Shingo; Hiroshi Kagawa
Journal:  J Artif Organs       Date:  2006       Impact factor: 1.731

8.  Successful thrombolysis for prosthetic pulmonary valve obstruction.

Authors:  J A Lopez; N E Strickman; B S Jin; X G Li; B Phan; B J Zeluff; S Wilansky
Journal:  Tex Heart Inst J       Date:  1995

9.  Obstruction of mechanical valve prostheses: clinical diagnosis and surgical or nonsurgical treatment.

Authors:  S Aoyagi; S Fukunaga; S Suzuki; Y Nishi; A Oryoji; K Kosuga
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

10.  Thrombolytic treatment for massive thrombosis of prosthetic cardiac valves.

Authors:  F Guerrero López; G Vázquez Mata; A Reina Toral; I Rodríguez Bailón; E Fernández Mondéjar; P Aranegui Lasuen
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.